Inside India’s Vaccine Divide

Differential Pricing and Super Profits

India, the pharmacy of the world is currently facing a devastating second wave of the COVID pandemic. With a surge in infections crossing the 400,000 mark on a daily basis, the population of over a billion people were pinning its hopes on the ongoing vaccination drive. This, as the world’s largest vaccine manufacturer, is staring […]

To read this article, log in here or subscribe here.
If you are logged in but can't read CP+ articles, check the status of your access here
In order to read CP+ articles, your web browser must be set to accept cookies.

Sumedha Pal is a New Delhi-based journalist.

CounterPunch Magazine Archive

Read over 400 magazine and newsletter back issues here

Support CounterPunch

Make a tax-deductible monthly or one-time donation and enjoy access to CP+.  Donate Now

Support our evolving Subscribe Area and enjoy access to all Subscribers content.  Subscribe